UPEI News

Media Releases

The University of Prince Edward Island celebrated today the launch of a new contract research company based partly on UPEI technology. Bio-valuation Outsourcing Solution (BioVOS) provides services to the pharmaceutical industry to test new drugs and treatments for neuro-inflammatory, metabolic, and cardiovascular disorders, including stroke and heart disease. “Pharmaceutical companies face real challenges when bringing a new drug to market,” says Dr. Tarek Saleh, Professor of Biomedical Sciences at UPEI’s Atlantic Veterinary College and CEO of BioVOS. “Drug development takes up to 15 years with a success rate of just one in five thousand at an average cost of more than a billion dollars. Contract research organizations, such as BioVOS, can help streamline that process and make it more affordable.” BioVOS has exclusive agreements in place to use more than one hundred in vivo and in vitro research models and techniques developed by the Atlantic Centre for Bioactive Valuation (ACBV) and other partners. The research of ACBV was made possible by generous funding from Innovation PEI and the Atlantic Canada Opportunities Agency (ACOA). Three Oaks Innovations...

Photo Stories